CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)
Lead Scientist at University of California Health
- Katy Tsai, MD (ucsf)
Dr. Katy K. Tsai is a medical oncologist and clinical researcher who specializes in treating advanced melanoma and other non-melanoma skin cancers, such as squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. Dr. Tsai graduated with a degree in comparative literature from Brown University before earning her medical degree from Brown.
- accepting new patients
- Start Date
- Completion Date
- BioAtla, Inc.
- Phase 1/2 research study
- Study Type
- Expecting 420 study participants
- Last Updated